American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$229M |
| 2 |
Johnson & Johnson
JNJ
|
+$202M |
| 3 |
JPMorgan Chase
JPM
|
+$193M |
| 4 |
Citizens Financial Group
CFG
|
+$174M |
| 5 |
Automatic Data Processing
ADP
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$288M |
| 2 |
Union Pacific
UNP
|
+$199M |
| 3 |
PNC Financial Services
PNC
|
+$196M |
| 4 |
NXP Semiconductors
NXPI
|
+$155M |
| 5 |
Cisco
CSCO
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.53% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 11.86% |
| 4 | Industrials | 10.85% |
| 5 | Consumer Discretionary | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBPX
601
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $13.8M | 0.01% |
597,648
-133,693
| -18% | -$2.9M |
|
602
Penske Automotive Group
PAG
$14.3B
| $13.8M | 0.01% |
266,197
-91,705
| -26% | -$4.47M |
|
603
Synopsys
SNPS
$79.2B
| $13.8M | 0.01% |
233,877
-75,249
| -24% | -$4.48M |
|
|
GMS
604
DELISTED
GMS Inc
GMS
| $13.6M | 0.01% |
465,257
-229,471
| -33% | -$5.59M |
|
605
ResMed
RMD
$32.7B
| $13.6M | 0.01% |
218,811
-389,335
| -64% | -$23.8M |
|
606
Coca-Cola
KO
$377B
| $13.5M | 0.01% |
326,086
-113,809
| -26% | -$4.74M |
|
|
RDC
607
DELISTED
Rowan Companies Plc
RDC
| $13.5M | 0.01% |
712,986
-248,596
| -26% | -$4.05M |
|
608
Nu Skin
NUS
$237M
| $13.5M | 0.01% |
281,840
+159,013
| +129% | +$8.91M |
|
|
MRT
609
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $13.4M | 0.01% |
1,208,655
+635,675
| +111% | +$7.1M |
|
|
TWO
610
Two Harbors Investment
TWO
$1.27B
| $13.3M | 0.01% |
190,539
+14,536
| +8% | +$990K |
|
611
Morgan Stanley
MS
$346B
| $12.9M | 0.01% |
306,393
-116,009
| -27% | -$4.39M |
|
612
BorgWarner
BWA
$14B
| $12.9M | 0.01% |
371,688
-367,121
| -50% | -$11.8M |
|
613
Western Alliance Bancorporation
WAL
$9B
| $12.7M | 0.01% |
+260,569
| New | +$11.2M |
|
|
ALE
614
DELISTED
Allete
ALE
| $12.6M | 0.01% |
196,405
-279,352
| -59% | -$17.1M |
|
615
LXP Industrial Trust
LXP
$3.58B
| $12.6M | 0.01% |
233,256
-8,826
| -4% | -$450K |
|
616
Graham Corp
GHM
$1.32B
| $12.6M | 0.01% |
567,639
-14,174
| -2% | -$290K |
|
617
Prosperity Bancshares
PB
$8.96B
| $12.5M | 0.01% |
174,704
-68,783
| -28% | -$4.3M |
|
618
Trip.com Group
TCOM
$28.2B
| $12.5M | 0.01% |
313,493
+2,318
| +0.7% | +$101K |
|
619
TSMC
TSM
$2.25T
| $12.5M | 0.01% |
433,178
+45,800
| +12% | +$1.38M |
|
|
WSTC
620
DELISTED
West Corporation
WSTC
| $12.4M | 0.01% |
502,759
-37,162
| -7% | -$862K |
|
621
Sabra Healthcare REIT
SBRA
$5.19B
| $12.3M | 0.01% |
505,647
+6,372
| +1% | +$146K |
|
622
Blackstone Mortgage Trust
BXMT
$2.43B
| $12.2M | 0.01% |
405,665
-233,776
| -37% | -$6.96M |
|
623
Shopify
SHOP
$198B
| $12.1M | 0.01% |
2,822,870
-223,270
| -7% | -$938K |
|
624
Utah Medical Products
UTMD
$228M
| $12M | 0.01% |
165,388
-12,562
| -7% | -$817K |
|
625
Neurocrine Biosciences
NBIX
$15.4B
| $12M | 0.01% |
310,235
-570,272
| -65% | -$25.8M |
|
Similar funds
American Century Companies's Q4 2016 Portfolio in Review
As of Q4 2016, American Century Companies held 1,486 positions worth $92.8B, up 1.9% from $91B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
American Century Companies's Q4 2016 filing shows 166 new, 494 increased, 617 reduced and 173 closed positions. Its largest new stake was Citizens Financial Group: 5,752,874 shares worth $205M. The largest sale was Pfizer, an estimated $288M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- American Century Companies's largest Q4 2016 buy was Citizens Financial Group: 5,752,874 shares worth $205M.
- American Century Companies added most to Chevron in Q4 2016, an estimated $229M increase.
- American Century Companies's biggest Q4 2016 reduction was Pfizer, cutting an estimated $288M.
- American Century Companies fully exited Liberty Global Class A in Q4 2016, selling an estimated $116M.
- American Century Companies's ten largest holdings make up 13% of its $92.8B portfolio in Q4 2016.
- American Century Companies opened 166 new positions and closed 173 in Q4 2016.
- American Century Companies's portfolio value rose 1.9% quarter-over-quarter to $92.8B.
Based on American Century Companies's 13F filing for Q4 2016, filed 3 Feb 2017.